Jan 24 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* PRELIMINARY RESULTS ON MDNA55 AND MDNA109 TO BE PRESENTED AT THE IMMUNO-ONCOLOGY 360° CONFERENCE
Jan 24 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* PRELIMINARY RESULTS ON MDNA55 AND MDNA109 TO BE PRESENTED AT THE IMMUNO-ONCOLOGY 360° CONFERENCE